Heart health continues to be a great concern; its management, even greater. Know these habits that are deteriorating your ...

Dr Joseph A Hill discusses the diagnosis and management of heart failure with preserved ejection fraction (HFpEF).

A recent study reveals a significant link between high BMI and increased breast cancer risk, particularly in postmenopausal ...

In a new consensus statement, the European Society of Cardiology has declared vaccinations for common infections to be a ...

In this high-yield, clinically focused session, Dr. Steven L. Cohn, one of the leading experts in perioperative medicine, discussed the new American College of Cardiology/American Heart Association ...

CVRx's FDA-approved heart failure therapy, strong growth potential, and discounted valuation make it a compelling speculative ...

A scientific statement has been published by the ACC regarding the management of obesity in adults with heart failure.

Cardiovascular disease (CVD) ranks as a primary driver of morbidity and mortality globally, pushing the boundaries of health care management and ...

Lifestyle therapy may not be enough to improve outcomes for patients with HF and obesity, but careful risk evaluation and ...

The American College of Cardiology has issued new guidelines recommending weight management medications as first-line treatments for eligible patients. This contrasts with prior guidelines that ...

GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.

Initially used for blood glucose control, the medications reduce cardiovascular events and mitigate heart failure hospitalization, regardless of diabetes status.